Ubs Asset Management Americas Inc Nevro Corp Transaction History

Ubs Asset Management Americas Inc

$381 Billion
Q3 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Nevro Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 1,000,000 shares of NVRO stock, worth $4.52 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,000,000

Previous 433,538 130.66%

Holding current value

$4.52 Million

Previous $3.65 Million 52.88%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.71 - $10.1 $2.67 Million - $5.72 Million	566,462 Added 130.66%	1,000,000 $5.58 Million
Q2 2024 Aug 13, 2024	BUY	$7.96 - $13.59 $3.14 Million - $5.36 Million	394,577 Added 1012.75%	433,538 $3.65 Million
Q3 2023 Nov 13, 2023	BUY	$18.22 - $25.85 $41,231 - $58,498	2,263 Added 6.17%	38,961 $748,000
Q4 2022 Feb 14, 2023	BUY	$36.43 - $49.4 $72,094 - $97,762	1,979 Added 5.7%	36,698 $1.45 Million
Q3 2022 Nov 14, 2022	SELL	$40.66 - $53.03 $354,839 - $462,792	-8,727 Reduced 20.09%	34,719 $1.62 Million
Q2 2022 Aug 12, 2022	SELL	$40.85 - $77.67 $42,238 - $80,310	-1,034 Reduced 2.32%	43,446 $1.9 Million
Q1 2022 May 16, 2022	BUY	$59.95 - $92.06 $400,226 - $614,592	6,676 Added 17.66%	44,480 $3.22 Million
Q4 2021 Feb 14, 2022	BUY	$81.07 - $121.29 $28,293 - $42,330	349 Added 0.93%	37,804 $3.06 Million
Q3 2021 Nov 15, 2021	SELL	$101.99 - $166.36 $47,629 - $77,690	-467 Reduced 1.23%	37,455 $4.36 Million
Q2 2021 Aug 16, 2021	BUY	$141.6 - $179.06 $46,303 - $58,552	327 Added 0.87%	37,922 $6.29 Million
Q1 2021 May 14, 2021	BUY	$132.81 - $182.18 $41,436 - $56,840	312 Added 0.84%	37,595 $5.24 Million
Q4 2020 Mar 01, 2021	BUY	$138.17 - $184.34 $241,797 - $322,595	1,750 Added 4.92%	37,283 $6.45 Million
Q3 2020 Nov 13, 2020	BUY	$114.09 - $145.51 $121,391 - $154,822	1,064 Added 3.09%	35,533 $4.95 Million
Q2 2020 Aug 14, 2020	SELL	$89.45 - $129.85 $113,243 - $164,390	-1,266 Reduced 3.54%	34,469 $4.12 Million
Q1 2020 May 15, 2020	BUY	$70.23 - $144.31 $136,456 - $280,394	1,943 Added 5.75%	35,735 $3.57 Million
Q4 2019 Feb 14, 2020	BUY	$76.41 - $117.54 $9,551 - $14,692	125 Added 0.37%	33,792 $3.97 Million
Q3 2019 Nov 14, 2019	BUY	$61.52 - $91.1 $422,457 - $625,583	6,867 Added 25.62%	33,667 $2.89 Million
Q2 2019 Aug 15, 2019	BUY	$58.04 - $66.99 $367,161 - $423,778	6,326 Added 30.9%	26,800 $0
Q1 2019 May 14, 2019	BUY	$35.52 - $62.62 $372,036 - $655,881	10,474 Added 104.74%	20,474 $0
Q4 2018 Feb 13, 2019	SELL	$35.43 - $56.29 $320,110 - $508,580	-9,035 Reduced 47.47%	10,000 $388,000
Q3 2018 Nov 14, 2018	BUY	$44.22 - $75.47 $24,099 - $41,131	545 Added 2.95%	19,035 $0
Q2 2018 Aug 14, 2018	BUY	$72.38 - $92.5 $72,814 - $93,055	1,006 Added 5.75%	18,490 $0
Q1 2018 May 14, 2018	BUY	$69.46 - $88.57 $173,233 - $220,893	2,494 Added 16.64%	17,484 $0
Q4 2017 Feb 09, 2018	SELL	$65.94 - $93.31 $54,664 - $77,353	-829 Reduced 5.24%	14,990 $0
Q3 2017 Nov 13, 2017	BUY	$80.87 - $91.08 $1.28 Million - $1.44 Million	15,819	15,819 $0

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $160M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Nevro Corp Transaction History